Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: Dan Hamilton who wrote (1046)	11/4/1999 9:42:00 PM
From: Planet 9	Respond to of 1728

Bingo! If I had purchased this stock at $35 or $40 and watched as it rose to $120 I think I would be prone to take a little profit. Let's consider, it has a market cap of $1.8B and annual sales of maybe $100M, using a valid but in today's world easily dethroned technology, with patent problems looming -- take the money and run. When it returns to levels where oxygen is available for prudent investors to breath then buy in again. I posted this before but if you would like to play the DNA device game for very little money and big upside look at Virtek Vision on the Toronto Stock Exchange and visit its web site and check out its DNA chip reader. The stock is less than 1X's revenue! Buy low, sell high.